patient stratification for clinical trials

Amprion is a diagnostics company focused on neurodegenerative disorders. It offers the SAAmplify-αSYN Plus seed amplification assay, described as the first clinically available, validated test that detects pathological α-synuclein in CSF with autopsy-confirmed accuracy for diseases such as Parkinson's, Lewy body dementia, multiple system atrophy, and Alzheimer's. The company was founded in 2014 and operates a CAP-accredited and CLIA-certified clinical laboratory in San Diego, California.

Read more

biomarker detectionclinical laboratory testingCSF testingseed amplification assay (SAA)skin biopsy testing